These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 9814467)

  • 1. Increased serum vascular endothelial growth factor levels and intrathyroidal vascular area in patients with Graves' disease and Hashimoto's thyroiditis.
    Iitaka M; Miura S; Yamanaka K; Kawasaki S; Kitahama S; Kawakami Y; Kakinuma S; Oosuga I; Wada S; Katayama S
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3908-12. PubMed ID: 9814467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of angiogenic molecules in autoimmune thyroid diseases and their correlation with laboratory and clinical features.
    Figueroa-Vega N; Sanz-Cameno P; Moreno-Otero R; Sánchez-Madrid F; González-Amaro R; Marazuela M
    J Clin Endocrinol Metab; 2009 Apr; 94(4):1145-53. PubMed ID: 19141578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid vascularity and blood flow are not dependent on serum thyroid hormone levels: studies in vivo by color flow doppler sonography.
    Bogazzi F; Bartalena L; Brogioni S; Burelli A; Manetti L; Tanda ML; Gasperi M; Martino E
    Eur J Endocrinol; 1999 May; 140(5):452-6. PubMed ID: 10229913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thyroid blood flow evaluation by color-flow Doppler sonography distinguishes Graves' disease from Hashimoto's thyroiditis.
    Vitti P; Rago T; Mazzeo S; Brogioni S; Lampis M; De Liperi A; Bartolozzi C; Pinchera A; Martino E
    J Endocrinol Invest; 1995 Dec; 18(11):857-61. PubMed ID: 8778158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Th1 and Th2 serum cytokine profiles characterize patients with Hashimoto's thyroiditis (Th1) and Graves' disease (Th2).
    Phenekos C; Vryonidou A; Gritzapis AD; Baxevanis CN; Goula M; Papamichail M
    Neuroimmunomodulation; 2004; 11(4):209-13. PubMed ID: 15249726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
    Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
    Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of thyroidectomy of serum VEGF levels in patients with Graves disease].
    Kołomecki K; Bartos M; Pomorski L; Kuzdak K
    Wiad Lek; 2001; 54(9-10):504-7. PubMed ID: 11816293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interferon gamma levels in autoimmune thyroid disease.
    Matsubayashi S; Kasuga Y; Sakatsume Y; Akasu F; Volpé R
    Clin Invest Med; 1990 Oct; 13(5):271-4. PubMed ID: 2125901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone modulates insulin-like growth factor-I(IGF-I) and IGF-binding protein-3, without mediation by growth hormone, in patients with autoimmune thyroid diseases.
    Inukai T; Takanashi K; Takebayashi K; Fujiwara Y; Tayama K; Takemura Y
    Horm Metab Res; 1999 Oct; 31(10):576-9. PubMed ID: 10596968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo.
    Sato K; Yamazaki K; Shizume K; Kanaji Y; Obara T; Ohsumi K; Demura H; Yamaguchi S; Shibuya M
    J Clin Invest; 1995 Sep; 96(3):1295-302. PubMed ID: 7657804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of thyroxine on serum soluble interleukin-2 receptor alpha levels in thyroid disorders.
    Zwirska-Korczala K; Berdowska A; Jochem J; Sitkiewicz A; Birkner E; Polaniak R; Jedrzejowska-Szypułka H; Korzonek-Szlacheta I
    J Clin Pharm Ther; 2004 Apr; 29(2):151-6. PubMed ID: 15068404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation.
    Tuttle RM; Fleisher M; Francis GL; Robbins RJ
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1737-42. PubMed ID: 11932308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating chemokines in patients with autoimmune thyroid diseases.
    Domberg J; Liu C; Papewalis C; Pfleger C; Xu K; Willenberg HS; Hermsen D; Scherbaum WA; Schloot NC; Schott M
    Horm Metab Res; 2008 Jun; 40(6):416-21. PubMed ID: 18415893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and VEGF receptor-1 (Flt-1) in Graves disease possibly correlated with increased vascular density.
    Nagura S; Katoh R; Miyagi E; Shibuya M; Kawaoi A
    Hum Pathol; 2001 Jan; 32(1):10-7. PubMed ID: 11172289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of Nigella sativa on thyroid function, serum Vascular Endothelial Growth Factor (VEGF) - 1, Nesfatin-1 and anthropometric features in patients with Hashimoto's thyroiditis: a randomized controlled trial.
    Farhangi MA; Dehghan P; Tajmiri S; Abbasi MM
    BMC Complement Altern Med; 2016 Nov; 16(1):471. PubMed ID: 27852303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Distribution of IgG subclasses of TgAb and TPOAb in sera from patients with Graves' disease, Graves' disease plus Hashimoto's thyroiditis and Hashimoto's thyrotoxicosis].
    Yuan S; Yu N; Gao Y; Huang W; He Y; Dong B; Lu G; Li M; Cai X; Peng D; Wang Y; Li T; Huang Y; Gao Y; Guo X; Shi B
    Zhonghua Yi Xue Za Zhi; 2014 Jan; 94(2):110-4. PubMed ID: 24721350
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preliminary clinical application of sICAM-1 RIA in three kinds of thyroid disease.
    Lu M; Fang P; Zhang Z; He H; Gao S; Hou B; Zheng R; Xiao Q; Yang L
    Chin Med J (Engl); 2002 Oct; 115(10):1552-5. PubMed ID: 12490109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid Doppler ultrasonography and resistive index in the evaluation of the need for ablative or antithyroid drug therapy in Graves' hyperthyroidism.
    Wang CY; Chang TC
    J Formos Med Assoc; 2001 Nov; 100(11):753-7. PubMed ID: 11802534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-1 levels in patients with disorders of the thyroid gland.
    Tilly N; Schneider JG; Leidig-Bruckner G; Sommer U; Kasperk C
    Exp Clin Endocrinol Diabetes; 2003 Apr; 111(2):80-4. PubMed ID: 12746758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pro- and anti-angiogenic VEGF mRNAs in autoimmune thyroid diseases.
    Rancier M; Zaaber I; Stathopoulou MG; Chatelin J; Saleh A; Marmouch H; El Shamieh S; Masson C; Murray H; Lamont J; Fitzgerald P; Mahjoub S; Said K; Tensaout BB; Mestiri S; Visvikis-Siest S
    Autoimmunity; 2016 Sep; 49(6):366-372. PubMed ID: 27494076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.